Lysosomes need to be acidic to digest cellular waste. They achieve this by pumping protons in. But pumping protons in without a way to let them out creates a problem: the acidity overshoots, and the digestive enzymes that need a specific pH window stop working. Too little acid and nothing gets digested. Too much acid and nothing gets digested. The lysosome needs a regulator, not just a pump.
TMEM175 is that regulator. It's an ion channel that conducts both potassium ions and protons, acting as an overflow valve that vents excess protons when the lysosome becomes too acidic. The valve holds the pH at the optimal point — not by preventing acidification, but by setting an upper limit on it.
The connection to Parkinson's disease is direct: mutations in TMEM175 break the valve. Without overflow regulation, lysosomes acidify past their functional window. Protein breakdown fails. Cellular waste accumulates. Neurons — which can't dilute waste through division — are the first cells to die from the buildup.
The structural insight here cuts deeper than the therapeutic promise. The disease isn't caused by a failure to acidify — it's caused by a failure to stop acidifying. The same process that makes the lysosome functional is the process that, unchecked, makes it dysfunctional. The pump was never the problem. The valve was. Every system that optimizes along a single axis needs a mechanism that says “enough.” TMEM175 is the lysosome's word for enough. Parkinson's is what happens when the cell loses the ability to say it.